Designing safer ADC facilities: Solving potent compound risk assessment

Session 1: 

Wednesday, June 10, 2026   

8 a.m. PST |  11 a.m. EST | 5 p.m. CET

Session 2:

Thursday, June 11, 2026

 10 a.m. CET | 2:30 p.m. IST | 5 p.m. HKT   

 

Scaling ADC manufacturing requires overcoming challenges in safety, process, and facility design. Potent payloads, multi-step workflows, and strict containment requirements make it essential to connect risk assessment with practical implementation from the start. 

In this webinar, you’ll learn how holistic potent compound risk assessments that span hazard identification, OEL/OEB determination, and task-based exposure analysis can directly inform smarter design and operational decisions. This is your opportunity to see how these insights translate into tangible improvements in facility layout, process flow, and operator protection. 

The session will also highlight how enabling technologies can reduce open handling, support containment strategies, and enhance process control across critical steps like conjugation and TFF. By aligning risk insights with fit-for-purpose solutions, teams can build safer, more efficient processes that are ready to scale. 

You’ll come away with a clearer view of how early collaboration between EHS, engineering, and process development teams leads to more robust ADC manufacturing environments — helping you reduce risk, improve consistency, and move forward with confidence. 

 

What You Will Learn:

  1. Understand the components of a holistic potent compound risk assessment for ADC facilities, from hazard ID to task-based exposure analysis.
  2. Identify where closed, single-use technologies (e.g., conjugation and TFF systems) support containment and process control needs defined by risk assessments.  
  3. Learn how to align consultants, EHS, engineering, and technology vendors early to ensure sound design and implementation of safe ADC operations.  

Please Complete the Form

Complete Form to Register

Meet Our Experts

Prashant Varma

Process Expert, Sartorius

Prashant is a biopharmaceutical professional with more than 15 years of experience in the industry. At Sartorius, he works on a global team within Sartorius helping customers develop and commercialize mAbs, ADCs, AAV, vaccines, and more. He also helps with post-commercialization optimization to improve processes and decrease manufacturing costs.  

Amy H. Snow, MHS, CIH, CSP

Senior Managing Industrial Hygienist, Trinity Consultants | Life Sciences - SafeBridge Consultants, Inc.   

Amy has more than 25 years of experience in industrial hygiene, safety, risk assessment, and EHS program implementation. She has been an AIHA and ACGIH volunteer and leader throughout her career. She served as the lead author for a cross-disciplinary team that published the AIHA Hazardous Drug Surface Contamination Guidance Document. Amy serves as a director on the AIHA Board of Directors.